How a false hydroxychloroquine narrative was created, and more

It is remarkable that a large series of events taking place over the past months produced a unified message about hydroxychloroquine (HCQ), and produced similar policies about the drug in the US, Canada, Australia, NZ and western Europe.  The message is that generic, inexpensive hydroxychloroquine (costing only $1.00 to produce a full course) is dangerous and should not…

Even worse than ‘Recovery,’ potentially lethal hydroxychloroquine study in patients near death

What could be worse than giving potentially lethal doses of hydroxychloroquine to Hospitalized Covid-19 patients? The REMAP-Covid study is using the same HCQ dose as the Recovery trial for 6 days.  But it is even worse for the following reasons: You have to be close to death, either on a ventilator or in shock, on…

Quick explanation of FDA’s Emergency Use Authorization/Retraction for hydroxychloroquine and chloroquine

The Trump administration arranged on March 28 for 30-60 million tablets of hydroxychloroquine and certain (unapproved, unlicensed) chloroquine tablets to be donated by manufacturers to the National Strategic Stockpile (NSS) under an Emergency Use Authorization (EUA).  The official who signed the EUA is the FDA’s Chief Scientist, Denise M. Hinton.  Denise Hinton is a nurse with a master’s degree,…

WHO and UK trials use potentially lethal hydroxychloroquine dose–according to WHO consultant

The Solidarity Trial is a WHO-led conglomeration of many national trials of treatments for Covid-19. In March alone, the WHO collected $108 million from donors to cover costs of Solidairy clinical trials. Per the WHO: As of 3 June 2020, more than 3500 patients have been recruited in 35 countries, with over 400 hospitals actively recruiting patients. Overall, over 100 countries…

End of content

End of content